<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00942019</url>
  </required_header>
  <id_info>
    <org_study_id>KGU-88/08</org_study_id>
    <nct_id>NCT00942019</nct_id>
  </id_info>
  <brief_title>Study of Bronchial Inflammation in Adolescent Smokers With and Without Obesity</brief_title>
  <official_title>Bronchial Inflammation in Adolescent Smokers With and Without Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators want to assess differences in lung function and bronchial inflammation of&#xD;
      young smokers and non-smokers with (BMI &gt; 30) and without obesity (BMI &lt; 25)(4 patient&#xD;
      groups). The aim of the study is to compare differences in lung function (VC, FEV1, VC/FEV1,&#xD;
      metacholine challenge) and bronchial inflammation in relation with smoking history and levels&#xD;
      of exhaled CO. For the latter the investigators will analyze the levels of IL-8, IL-6, TNF&#xD;
      alpha and INF gamma and mRNA of LBP, TLR2 and TLR4 in sputum. Further, inflammatory markers&#xD;
      e.g. low CRP and inflammatory cytokines levels in the blood will be investigated. The aim is&#xD;
      to describe a early stage of chronic obstructive pulmonary disease caused by cigarette smoke&#xD;
      in juvenile smokers, and the relationship between bronchial inflammation and obesity in&#xD;
      adolescents.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tobacco smoke is the crucial factor at the beginning and in the course of the bronchial&#xD;
      inflammation leading to COPD. It has been shown that cigarette smoke in vitro leads to a MAP&#xD;
      kinase and NF-κB-dependent increase of pro-inflammatory cytokines, and inhibits&#xD;
      bacteria-induced expression of β-defensins. Several studies revealed an increase of&#xD;
      inflammatory cytokines like IL-8 and TNF in the sputum of smokers. Further studies&#xD;
      demonstrated an up regulation of LTB4 and LBP possibly due to the LPS derived from tobacco&#xD;
      smoke. Hasday et al could show that up to 15 ng per cigarette LPS is released. In principle,&#xD;
      the cigarette smoke exposure liked a mild LPS inhalation. In separate work, we could show&#xD;
      that LPS inhalation in healthy non-smokers to an increase of CRP and LBP concentrations in&#xD;
      the serum lead. In another study of adolescents, 24 smokers (age 17.7 years) and 24&#xD;
      non-smoking (age 17.5 years) were compared. The CO in smokers was significantly increased,&#xD;
      and the NO concentrations decreased. At the same time there was a significantly greater&#xD;
      bronchial hyperreagibility in the smoker group.&#xD;
&#xD;
      According to a recent study in Germany (KiGGS study), already 31% of the adolescents' boys&#xD;
      and 32% of the girls do smoke. The social status is of great importance. Boys and girls from&#xD;
      families with a low social status smoke more frequently than those from families with&#xD;
      middle-and especially with higher social status. Similarly obesity is linked to the social&#xD;
      status with overweight occurring more often in families with a lower social status.&#xD;
&#xD;
      A visceral obesity is closely associated with the risk of type-2-diabetes as well as other&#xD;
      aspects of the metabolic syndrome. However, the existing insulin resistance is of fundamental&#xD;
      importance. Due to increased visceral fat depots and subsequently increased release of&#xD;
      proinflammatory proteins various complications do occur.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bronchial inflammatory in adolescents smokers with and without obesity</measure>
    <time_frame>one day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association of bronchial inflammatory parameters in sputum and in the blood</measure>
    <time_frame>one day</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">110</enrollment>
  <condition>Obesity</condition>
  <condition>Tobacco Smoking</condition>
  <arm_group>
    <arm_group_label>obese smokers</arm_group_label>
    <description>BMI &gt; 30 kg/m2 CO ≥ 15 ppm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-obese smokers</arm_group_label>
    <description>BMI &lt; 25 kg/m2 CO ≥ 15 ppm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>obese non-smokers</arm_group_label>
    <description>BMI &gt; 30 kg/m2 CO ≤ 6 ppm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-obese non-smokers</arm_group_label>
    <description>BMI &lt; 25 kg/m2 CO ≤ 6 ppm</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum: total IgE, RAST urin: cotinine, leukotrienes sputum: leukotrienes, white cells whole&#xD;
      blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Youth&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  informed consent&#xD;
&#xD;
          -  age between 14 and 22 years&#xD;
&#xD;
          -  smokers CO ≥ 15 ppm&#xD;
&#xD;
          -  non-smokers CO ≤ 6 ppm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Asthma &gt; GINA I°&#xD;
&#xD;
          -  others chronic diseases or infections (e.x. HIV, tuberculosis, malignancy)&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  therapy with systemic corticosteroids&#xD;
&#xD;
          -  permanent treatment with inhaled corticosteroids&#xD;
&#xD;
          -  documented alcohol, substance, and/or drug abuse&#xD;
&#xD;
          -  incapability to perform all study procedure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>22 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Zielen, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children´s Hospital, Goethe-University, Frankfurt, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital, Goethe-University</name>
      <address>
        <city>Frankfurt/Main</city>
        <zip>60596</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Karimi K, Sarir H, Mortaz E, Smit JJ, Hosseini H, De Kimpe SJ, Nijkamp FP, Folkerts G. Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages. Respir Res. 2006 Apr 19;7:66.</citation>
    <PMID>16620395</PMID>
  </reference>
  <reference>
    <citation>Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Gramiccioni E, Barnes PJ. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Respir J. 2003 Apr;21(4):589-93.</citation>
    <PMID>12762340</PMID>
  </reference>
  <reference>
    <citation>Garey KW, Neuhauser MM, Robbins RA, Danziger LH, Rubinstein I. Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest. 2004 Jan;125(1):22-6.</citation>
    <PMID>14718416</PMID>
  </reference>
  <reference>
    <citation>Csoma Z, Kharitonov SA, Balint B, Bush A, Wilson NM, Barnes PJ. Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med. 2002 Nov 15;166(10):1345-9. Epub 2002 Sep 5.</citation>
    <PMID>12406853</PMID>
  </reference>
  <reference>
    <citation>Sebastian A, Pehrson C, Larsson L. Elevated concentrations of endotoxin in indoor air due to cigarette smoking. J Environ Monit. 2006 May;8(5):519-22. Epub 2006 Mar 27.</citation>
    <PMID>16688352</PMID>
  </reference>
  <reference>
    <citation>Kitz R, Rose MA, Borgmann A, Schubert R, Zielen S. Systemic and bronchial inflammation following LPS inhalation in asthmatic and healthy subjects. J Endotoxin Res. 2006;12(6):367-74.</citation>
    <PMID>17254391</PMID>
  </reference>
  <reference>
    <citation>KiGGS Study of Robert Koch Institut</citation>
  </reference>
  <reference>
    <citation>Kornmann O et al. Influence of second hand tobacco smoke exposure on inflammatory parameters in induced sputum Abstract ATS 2008</citation>
  </reference>
  <verification_date>July 2010</verification_date>
  <study_first_submitted>July 17, 2009</study_first_submitted>
  <study_first_submitted_qc>July 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2009</study_first_posted>
  <last_update_submitted>July 2, 2010</last_update_submitted>
  <last_update_submitted_qc>July 2, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 5, 2010</last_update_posted>
  <responsible_party>
    <name_title>Prof. Stefan Zielen</name_title>
    <organization>Goethe-University, Frankfurt, Germany</organization>
  </responsible_party>
  <keyword>BMI</keyword>
  <keyword>obesity</keyword>
  <keyword>CO</keyword>
  <keyword>tobacco smoking</keyword>
  <keyword>adolescents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

